Japanese regulators approved AstraZeneca and Astellas Pharma's Symbicort Turbuhaler to treat chronic obstructive pulmonary di -More- …
TOKYO, June 22 (Reuters) - Astellas Pharma Inc said on Friday it has received approval for additional use of its Symbicort Turbuhaler drug treatment for adult bronchial asthma in Japan beyond its curr…
